Goldman Sachs Bullish On Medco Health (MHS)

In a research report released today by Goldman Sachs GS, the firm's analysts said that they are upgrading shares of Medco Health Solutions MHS to Buy and increasing their price target to $76. They cited Medco's relative valuation to peers, earnings acceleration, and "most importantly, greater comfort with the 2011 selling season following CVS/WAG disruption and recent checks." Goldman's 12-month price target for MHS of $76 implies 18.9x 2011 EPS . GS now expects for MHS to earn $4.02 per share in 2011. They expect EPS to grow to $5.72 by 2013. During today's trading session, MHS has gained 1.35% to $61.36. Medco Health Solutions, Inc. (MHS) is a healthcare company. It provides clinically-driven pharmacy services designed to improve the quality of care and lower total healthcare costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans.